Skip to main content
logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.61
-0.01 (-0.07%)
Sep 1, 2026, 10:10 AM EDT - Market open

Summit Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.711.81
Revenue Growth
-----61.03%110.35%
Gross Profit
----0.711.81
Operating Income
-874.84-1,094-210.99-88.74-63.62-86.19
Net Income
-856.09-1,080-221.32-614.93-78.78-88.6
Earnings Per Share
-1.12-1.44-0.31-0.99-0.41-0.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
690.68713.45412.35186.24348.6171.79
Total Debt
20.3820.897.22106.1518.762.78
Net Cash (Debt)
670.29692.56405.1380.14-170.1669.01
Net Cash Growth
129.30%70.95%405.51%--4.63%
Net Cash Per Share
0.880.930.560.13-0.880.75

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-458.43-322.93-142.11-76.76-41.58-72.59
Capital Expenditures
-1.39-0.66-0.14-0.13-0.62-0.31
Free Cash Flow
-459.82-323.59-142.25-76.89-42.21-72.89
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
-----9024.25%-4764.29%
Pretax Margin
-----11174.75%-4897.84%
Profit Margin
-----11174.75%-4897.84%
FCF Margin
-----5986.67%-4029.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----1272.24145.30